A Hydrogen-Bonded Organic Framework-Based Mitochondrion-Targeting Bioorthogonal Platform for the Modulation of Mitochondrial Epigenetics C Huang, C Zhao, Y Sun, T Feng, J Ren, X Qu Nano Letters, 2024 | | 2024 |
Polyvalent DNA-based bioorthogonal nano-agonist for robust chemo-immunotherapy Y You, J Zhu, F Pu, W Wang, M Jiang, J Ren, X Qu Materials Today 75, 57-70, 2024 | | 2024 |
An ATPase-Mimicking MXene nanozyme pharmacologically breaks the ironclad defense system for ferroptosis cancer therapy H Wang, X Liu, X Yan, Y Du, F Pu, J Ren, X Qu Biomaterials 307, 122523, 2024 | | 2024 |
Mitochondria-mediated self-cycling nanoreactor enabling uninterrupted oxidative damage for enhanced chemodynamic therapy S Wu, H Wang, Y Wei, L Kang, T Cui, Y Huang, Z Liu, F Pu, J Ren Colloids and Surfaces B: Biointerfaces, 113990, 2024 | | 2024 |
A step by step protocol for stabilizing specific DNA G-quadruplexes by CRISPR guided G-quadruplex binding proteins and ligands Z Liu, J Yang, X Liao, C Zhao, J Ren, X Qu | | 2024 |
On‐Demand Activatable and Integrated Bioorthogonal Nanocatalyst against Biofilm‐Associated Infections Y Sun, H Zhao, F Pu, H Liu, L Chen, J Ren, X Qu Advanced Healthcare Materials, 2400899, 2024 | | 2024 |
An Alkaline Nanocage Continuously Activates Inflammasomes by Disrupting Multiorganelle Homeostasis for Efficient Pyroptosis A Song, W Wang, H Wang, Y Ji, Y Zhang, J Ren, X Qu ACS Applied Materials & Interfaces 16 (19), 24295-24307, 2024 | | 2024 |
Sensitizing cuproptosis by endogenous copper-triggered bioorthogonal nanoremodeler J Zhu, Y You, W Zhang, W Wang, M Jiang, F Pu, J Ren, X Qu Nano Today 55, 102196, 2024 | 2 | 2024 |
A Self‐Adaptive Pyroptosis Inducer: Optimizing the Catalytic Microenvironment of Nanozymes by Membrane‐Adhered Microbe Enables Potent Cancer Immunotherapy W Wang, L Zhang, Y Zhang, X Liu, A Song, J Ren, X Qu Advanced Materials 36 (14), 2310063, 2024 | 7 | 2024 |
Single-Atom Catalysts Mediated Bioorthogonal Modulation of N6-Methyladenosine Methylation for Boosting Cancer Immunotherapy M Sun, X Liu, Z Liu, W Zhang, G Li, J Ren, X Qu Journal of the American Chemical Society 146 (12), 8216-8227, 2024 | | 2024 |
Bioorthogonal Aptamer‐ATTEC Conjugates for Degradation of Alpha‐Synuclein via Autophagy‐Lysosomal Pathway X Liao, G Qin, Z Liu, J Ren, X Qu Small 20 (8), 2306760, 2024 | 3 | 2024 |
MOFs Modulate Copper Trafficking in Tumor Cells for Bioorthogonal Therapy Y Wei, H Zhao, Z Liu, J Yang, J Ren, X Qu Nano Letters 24 (4), 1341-1350, 2024 | 1 | 2024 |
Targeted inhibition of pyroptosis via a carbonized nanoinhibitor for alleviating drug-induced acute kidney injury Y Ji, H Wang, X Liu, Z Zhu, A Song, L Chen, J Ren Journal of Materials Chemistry B, 2024 | | 2024 |
Target‐Specific Bioorthogonal Reactions for Precise Biomedical Applications Z Liu, M Sun, W Zhang, J Ren, X Qu Angewandte Chemie 135 (49), e202308396, 2023 | 12 | 2023 |
Transforming intratumor bacteria into immunopotentiators to reverse cold tumors for enhanced immuno-chemodynamic therapy of triple-negative breast cancer X Liu, M Sun, F Pu, J Ren, X Qu Journal of the American Chemical Society 145 (48), 26296-26307, 2023 | 5 | 2023 |
A Homing Missile‐Like Nanotherapeutic with Single‐Atom Catalytic Sites for In Situ Elimination of Intracellular Bacterial Pathogens H Liu, X Liu, H Wang, J Ren, X Qu Small 19 (37), 2207510, 2023 | 8 | 2023 |
Chirality‐Dependent Reprogramming of Macrophages by Chiral Nanozymes Y Zhang, T Cui, J Yang, Y Huang, J Ren, X Qu Angewandte Chemie International Edition 62 (34), e202307076, 2023 | 15 | 2023 |
A Polyoxometalate‐Based Pathologically Activated Assay for Efficient Bioorthogonal Catalytic Selective Therapy H Zhao, C Zhao, Z Liu, J Yi, X Liu, J Ren, X Qu Angewandte Chemie International Edition 62 (32), e202303989, 2023 | 10 | 2023 |
A DNA‐Gated and Self‐Protected Bioorthogonal Catalyst for Nanozyme‐Assisted Safe Cancer Therapy Y Zhang, L Zhang, W Wang, Q Deng, M Liu, Z Zhu, H Liu, J Ren, X Qu Angewandte Chemie International Edition 62 (32), e202306395, 2023 | 8 | 2023 |
A bimetallic nanoplatform for STING activation and CRISPR/Cas mediated depletion of the methionine transporter in cancer cells restores anti-tumor immune responses Y Huang, G Qin, TT Cui, C Zhao, J Ren, X Qu Nature Communications 14 (1), 4647, 2023 | 23 | 2023 |